Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引：113
作者：
Fenaux, P. [1 ,2 ]
Haase, D. [3 ]
Santini, V [4 ]
Sanz, G. F. [5 ,6 ]
Platzbecker, U. [7 ]
Mey, U. [8 ]
机构：
[1] Hop St Louis, AP HP, Grp Francophone Myelodysplasies GFM, Serv Hematol Clin,Dept Hematol, Paris, France
[2] Paris 7 Univ, Paris, France
[3] Univ Med Ctr, Dept Hematol & Med Oncol, G6ttingen, Germany
[4] Univ Florence, AOU Careggi, MDS Unit, Haematol, Florence, Italy
[5] Hosp Univ La Fe, Dept Haematol, Valencia, Spain
[6] Inst Salud Carlos III, CIBERONC, Ctr Invest Biomed Red Canc, Madrid, Spain
[7] Univ Hosp Leipzig, Med Clin & Policlin 1, Dept Hematol & Cellular Therapy, Leipzig, Germany
[8] Kantonsspital Graubuenden, Dept Oncol & Haematol, Chur, Switzerland
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷 / 02期
关键词：
Myelodysplastic syndromes; Clinical Practice Guidelines; diagnosis; treatment; follow-up; ACUTE MYELOID-LEUKEMIA; TRANSFUSION-DEPENDENT PATIENTS; PROGNOSTIC SCORING SYSTEM; STEM-CELL TRANSPLANTATION; INTERNATIONAL WORKING GROUP; CONVENTIONAL CARE REGIMENS; ABERRANT DNA METHYLATION; IRON CHELATION-THERAPY; RANDOMIZED PHASE-II; DOSE ARA-C;
D O I：
10.1016/j.annonc.2020.11.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：142 / 156
页数：15
相关论文
共 127 条
[1]   Myelodysplastic syndromes [J].
Ades, Lionel ;
Itzykson, Raphael ;
Fenaux, Pierre .
LANCET, 2014, 383 (9936) :2239-2252
[2]  
AKSOY M, 1987, BRIT J IND MED, V44, P785
[3]   The myelodysplastic syndromes flow cytometric score: a three-parameter prognostic flow cytometric scoring system [J].
Alhan, C. ;
Westers, T. M. ;
Cremers, E. M. P. ;
Cali, C. ;
Witte, B. I. ;
Ossenkoppele, G. J. ;
van de Loosdrecht, A. A. .
LEUKEMIA, 2016, 30 (03) :658-665
[4]   Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes A Randomized Trial [J].
Angelucci, Emanuele ;
Li, Junmin ;
Greenberg, Peter ;
Wu, Depei ;
Hou, Ming ;
Montano Figueroa, Efreen Horacio ;
Guadalupe Rodriguez, Maria ;
Dong, Xunwei ;
Ghosh, Jagannath ;
Izquierdo, Miguel ;
Garcia-Manero, Guillermo .
ANNALS OF INTERNAL MEDICINE, 2020, 172 (08) :513-+
[5]   The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia [J].
Arber, Daniel A. ;
Orazi, Attilio ;
Hasserjian, Robert ;
Thiele, Jurgen ;
Borowitz, Michael J. ;
Le Beau, Michelle M. ;
Bloomfield, Clara D. ;
Cazzola, Mario ;
Vardiman, James W. .
BLOOD, 2016, 127 (20) :2391-2405
[6]   Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation [J].
Armand, Philippe ;
Kim, Haesook T. ;
Cutler, Corey S. ;
Ho, Vincent T. ;
Koreth, John ;
Alyea, Edwin P. ;
Soiffer, Robert J. ;
Antin, Joseph H. .
BLOOD, 2007, 109 (10) :4586-4588
[7]   CHIP, ICUS, CCUS and other four-letter words [J].
Bejar, R. .
LEUKEMIA, 2017, 31 (09) :1869-1871
[8]   Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes [J].
Bejar, Rafael ;
Stevenson, Kristen E. ;
Caughey, Bennett A. ;
Abdel-Wahab, Omar ;
Steensma, David P. ;
Galili, Naomi ;
Raza, Azra ;
Kantarjian, Hagop ;
Levine, Ross L. ;
Neuberg, Donna ;
Garcia-Manero, Guillermo ;
Ebert, Benjamin L. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27) :3376-3382
[9]   Clinical Effect of Point Mutations in Myelodysplastic Syndromes [J].
Bejar, Rafael ;
Stevenson, Kristen ;
Abdel-Wahab, Omar ;
Galili, Naomi ;
Nilsson, Bjoern ;
Garcia-Manero, Guillermo ;
Kantarjian, Hagop ;
Raza, Azra ;
Levine, Ross L. ;
Neuberg, Donna ;
Ebert, Benjamin L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) :2496-2506
[10]   Clinical relevance of cytogenetics in myelodysplastic syndromes [J].
Bernasconi, Paolo ;
Boni, Marina ;
Cavigliano, Paola Maria ;
Calatroni, Silvia ;
Giardini, Ilaria ;
Rocca, Barbara ;
Zappatore, Rita ;
Dambruoso, Irene ;
Caresana, Marilena .
ESTROGENS AND HUMAN DISEASES, 2006, 1089 :395-410
12345678910